Epilepsy

NMOSD

Multiple Sclerosis

MS Advanced Practice Providers

MS and Demyelinating Disorders

Parkinson Disease

Movement Disorders

Dementia and Alzheimer Disease

Chronic Inflammatory Demyelinating Polyneuropathy

Muscular Dystrophy

Ataxia

Neuromuscular

Stroke

Migraine

Headache and Migraine

Narcolepsy

Insomnia

Sleep Disorders

News

Media

All Videos

Medical World News

Podcasts

Weekly Recap

Cure Connections

Insights

News Network

NeurologyLive Peer Exchange

Medcast Podcasts

Medcast Videos

Peers & Perspectives

Roundtable Discussions

Conferences

Conference Coverage

Conference Listing

CME/CE

Partners

Publications

NeurologyLive

Bridging the Gaps

International Journal of MS Care

Resources

Expert Authors

FDA News

Features

Fellows' Corner

Future Leaders in Neurology

Giants of Multiple Sclerosis

Interactive Tools

Live Events

Neurology Resources

Virtual Events

Subscribe

Articles

A new study revealed stark racial and socioeconomic disparities in pediatric neuromyelitis optica spectrum disorder outcomes, underscoring the need for targeted interventions.

Race, Socioeconomic Status Play Major Role in Disparities Seen in Pediatric NMOSD Outcomes

Over the 6-month treatment period, patients saw improvements in cataplexy frequency, excessive daytime sleepiness, cognition, and work productivity with AXS-12.

Axsome to File NDA Following Positive Phase 3 Results of AXS-12 in Narcolepsy

Videos

The pediatric neurologist at Duke Health and chief executive officer at Theranica talked about a remote electrical neuromodulation wearable that showed promising results for the treatment and prevention of migraine in pediatric patients. [WATCH TIME: 5 minutes]

Advancing the Treatment of Pediatric Migraine With Nerivio REN Wearable: Klaus Werner, MD & Alon Ironi

The vice president of scientific engagement at the Alzheimer's Association discussed advancements in blood biomarker tests, their use in specialty care, and the development of clinical guidelines for broader integration.

NeuroVoices: Rebecca M. Edelmayer, PhD, on Advancing Blood Biomarkers in Alzheimer Disease for Earlier Diagnosis and Treatment Intervention

Here's the latest multidisciplinary multiple sclerosis (MS) research from the International Journal of MS Care.

Research from IJMSC October 2024

The neurologist in the Headache Center at Cleveland Clinic shared her post perspective on the 2024 AHS Scottsdale meeting which highlighted advancements in headache medicine and the growing impact of the field on patient care. [WATCH TIME: 5 minutes]

Highlights on Exploring Advances in Headache Medicine from AHS Scottsdale 2024: MaryAnn Mays, MD

The epilepsy specialist and Cleveland Clinic’s Chief Research and Information Officer discussed the wide-spread applicability of scalp EEG and the potential for machine learning models to help predict epilepsy surgery outcomes. [WATCH TIME: 4 minutes]

Scalability of Scalp EEG as a Tool for Epilepsy Surgery Outcomes: Lara Jehi, MD, MHCDS

Dean and chief academic officer at the University of Miami Miller School of Medicine.

The dean and chief academic officer at the University of Miami Miller School of Medicine discussed the university’s investment in computational biology to advance aging and neuroscience research. [WATCH TIME: 5 minutes]

Driving Innovation in Aging and Neurodegenerative Research: Henri Ford, MD, MHA 

NeurologyLive is your direct connection to the latest neurology news and interviews with expert neurologists in multimedia formats.

About Us

Advisory Board

Editorial

Contact Us

Advertise

Contact MJH LS

Do Not Sell My Information

Terms and Conditions

Privacy

NeurologyLive – Clinical Neurology News and Neurology Expert Insights

Facebook

LinkedIN

YouTube

Spotlight

AANEM 2024

CTAD 2024

MDS 2024

Clinical Focus

Dementia/Alzheimer

Headache/Migraine

Video Series

Cervical Dystonia and Chronic Migraine Comorbidity: Background, Diagnosis, and Treatment

Review characteristics and comorbidities of cervical dystonia and treatment options

Grace Forde, MD

Christopher Rhyne, MD

Ramon Rodriguez, MD, FAAN

OnabotulinumtoxinA in Cervical Dystonia

Explore pivotal phase 3 trial data and real-world evidence regarding onabotulinumtoxinA for the treatment of cervical dystonia.

Aikaterini (Katie) Kompoliti, MD

Botulinum Toxins: Dosing and Duration of Treatment

Examine the impact of dose on duration of effect when using botulinum toxins for the treatment of cervical dystonia.

H. A. (Buz) Jinnah, MD, PhD

OnabotulinumtoxinA: Manufacturing, Non-interchangeability, and Non-Medical Switching

Learn how onabotulinumtoxinA is made, why botulinum toxins are non-interchangeable and why it matters.

Mitchell Brin, MD, FAAN, FANA, FAHS

Jack W. Tsao, MD, DPhil

Putting the Pieces Together: Cervical Dystonia Diagnosis, Comorbidities, and Treatment

Putting the Pieces Together: Cervical Dystonia Diagnosis, Comorbidities, and Treatment

Clinical Perspective presented by:

Program Objective